Social Survey Research Information Co., Ltd.

May 31st, 2018  -  Social Survey Research Information Co., Ltd.

Launch of PatientsMap China 2018

“Hypertension” is the most commonly seen disease by the physicians in China, followed by “diabetes” and “dyslipidemia”.

May 31st, 2018

Social Survey Research Information Co., Ltd.

 
 

Launch of PatientsMap China 2018

 

“Hypertension” is the most commonly seen disease by the physicians in China, followed by “diabetes” and “dyslipidemia”.

 

On June 4th, 2018, SSRI and M3 will launch PatientsMap China 2018.

PatientsMap Japan, which is updated on an annual basis, is a database from over 20,000 physicians uncovering the type of diseases that they see and its number of patients for approximately 400 different diseases.  US version and UK version of PatientsMap are also available, and this Chinese version makes it the 4th country for the PatientMap series.

PatientsMap China 2018 contains data for over 10,000 physicians collected via M3’s Chinese physician portal site medlive.cn

 

 

“Hypertension” is the most commonly seen disease by the Chinese physicians

According to PatientsMap 2018 China, “hypertension” is the most commonly seen disease by the Chinese physicians with 70.7% of the physicians answering that they see such patients. “Hypertension” was followed by other life-style diseases such as “diabetes (67.6%)” and “dyslipidemia (54.7%)”.

In comparison to Japan, life-style diseases such as “hypertension” “diabetes” “dyslipidemia” and “gout/hyperuricemia” are commonly seen by physicians in both countries. However in Japan, while allergy related conditions such as “allergic rhinitis” and “bronchial asthma” are commonly seen, in China, non-allergy related respiratory conditions such as “acute upper respiratory tract infection” and “pneumonia” are more commonly seen.

When comparing China and US, lifestyle diseases such as “hypertension” and “diabetes”, along with “acute upper respiratory tract infection” are commonly seen by physicians in both countries.

 

Table 1. PatientsMap 2018 China – top 10 diseases seen (n=10,285)
Rank% seen
1Hypertension70.7%
2Diabetes67.6%
3Dyslipidemia (Hyperlipidemia)54.7%
4Acute upper respiratory tract infection51.6%
5Pneumonia50.7%
6Cerebral infarction44.9%
7COPD44.3%
8Constipation39.9%
9Peptic ulcer37.8%
10Gout/hyperuricemia37.2%
 
 
 
Table 2. PatientsMap 2017 Japan – top 10 diseases seen (n=20,135)
Rank% seenRank in China
1Hypertension63.8%1
2Diabetes58.2%2
3Constipation55.9%8
4Dyslipidemia (Hyperlipidemia)51.0%3
5GERD / NERD50.3%-
6Seasonal allergic rhinitis / hay fever46.8%-
7Bronchial asthma43.9%-
8Gout/hyperuricemia41.9%10
9Pneumonia41.1%5
10Gastritis and duodenitis39.2%-
 
Table 3. PatientsMap 2016 US – top 10 diseases seen (n=5,034)
Rank% seenRank in China
1GERD / NERD50.1%-
2Hypertension46.0%1
3Iron deficiency anemia44.2%-
4Diabetes43.9%2
5Constipation43.6%8
6Depression43.4%-
7Obesity43.0%-
8Urinary tract infection41.9%-
9Lower back pain40.3%-
10Acute upper respiratory tract infection39.7%4
 
 
Outline of PatientsMap 2018 China
The data for this product is collected by random sampling per department via “medlive.cn” panel, which is a portal site for healthcare professionals in China operated by M3 Inc.
 
Disease coverage:357 diseases/conditions
Sample:Medlive.cn panel
Sample size:n=10,285 (various departments)
Methodology:Online survey
Study period:January 3rd – March 6th, 2018
Study topics:-        Diseases/conditions seen
-        Number of patients seen per month (per disease/condition)
-        Number of patients in which they prescribe medications for that disease/condition
-        Diseases in which they wish for new product development
-        Sales rep visitations in the past month (69 manufacturers)

 

■Contact Information:
patientsmap@ssri.com

 

 

■ Social Survey Research Information Co., Ltd.

Established:                      April 1982

Capital:                              27 million JPY

President & CEO: Takashi Makita

Number of staffs:              137

Address:                            Tokyo (HQ)

NMF Shinjuku East Bldg. 2F,
10-5 Tomihisacho, Shinjuku-ku, Tokyo 162-0067 JAPAN

Osaka office:

Daimei Bldg. 4F, 4-6-3 Hirano-cho, Chuo-ku, Osaka 541-0046

Affiliate companies:          PD Research, SSRI China, SSRI Asia Pacific

URL                                /

 

 

 

 

■ M3 Inc.

Established:                      September 2000

Capital:                              15.3 billion JPY

Representative director:   Itaru Tanimura

Number of staffs:              4,370

Address:                            1-11-44 Akasaka, Minato-ku, Tokyo 107-0052

URL https://corporate.m3.com/

 

 

■ Medlive.cn

Established:                      April 2013

Capital:                             2 million CNY

General manager:            Tian Liping

Number of staffs:             210

Address:                           Beijing Red Manor International Bonded Innovation Park E-1,

Baijialou 1, Chaoyang North Road, Chaoyang District,

Beijing 100024

URL: https://www.medlive.cn/